Skip to content

Clinical trials

Observational Thyroid Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thyroid Neoplasms Phase: Observational Clear all

229 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20022
20031
20043
20052
20062
20073
20086
20095
201010
201111
20126
20136
20147
20157
201613
201710
201811
201911
20209
202113
202221
202315
202420
202516
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed95
Recruiting51
Unknown status43
Active, not recruiting16
Not yet recruiting11
Withdrawn6
Enrolling by invitation4
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)11
Fujian Medical University7
Assiut University6
Memorial Sloan Kettering Cancer Center6
National Taiwan University Hospital6
Chinese PLA General Hospital3
Fondazione Policlinico Universitario Agostino Gemelli IRCCS3
Fudan University3
IRCCS Azienda Ospedaliero-Universitaria di Bologna3
Istituto Auxologico Italiano3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thyroid Neoplasms229
Thyroid Nodule35
Thyroid Diseases22
Thyroid Cancer, Papillary18
Breast Neoplasms15
Neoplasms11
Lung Neoplasms10
Prostatic Neoplasms10
Pancreatic Neoplasms9
Melanoma8

Trials

Showing 76 to 100 of 229. Each trial links to its page on Pharma Observatory.

129 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.